These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26147850)

  • 1. Social media and pharmacovigilance: A review of the opportunities and challenges.
    Sloane R; Osanlou O; Lewis D; Bollegala D; Maskell S; Pirmohamed M
    Br J Clin Pharmacol; 2015 Oct; 80(4):910-20. PubMed ID: 26147850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of listening social media for pharmacovigilance purposes: a systematic review.
    Convertino I; Ferraro S; Blandizzi C; Tuccori M
    Expert Opin Drug Saf; 2018 Nov; 17(11):1081-1093. PubMed ID: 30285501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining Adverse Drug Reactions in Social Media with Named Entity Recognition and Semantic Methods.
    Chen X; Deldossi M; Aboukhamis R; Faviez C; Dahamna B; Karapetiantz P; Guenegou-Arnoux A; Girardeau Y; Guillemin-Lanne S; Lillo-Le-Louët A; Texier N; Burgun A; Katsahian S
    Stud Health Technol Inform; 2017; 245():322-326. PubMed ID: 29295108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review.
    Golder S; O'Connor K; Wang Y; Klein A; Gonzalez Hernandez G
    JMIR Public Health Surveill; 2024 Sep; 10():e59167. PubMed ID: 39240684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOCIAL MEDIA MINING SHARED TASK WORKSHOP.
    Sarker A; Nikfarjam A; Gonzalez G
    Pac Symp Biocomput; 2016; 21():581-92. PubMed ID: 26776221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filtering big data from social media--Building an early warning system for adverse drug reactions.
    Yang M; Kiang M; Shang W
    J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public Perspectives of Using Social Media Data to Improve Adverse Drug Reaction Reporting: A Mixed-Methods Study.
    Bulcock A; Hassan L; Giles S; Sanders C; Nenadic G; Campbell S; Dixon W
    Drug Saf; 2021 May; 44(5):553-564. PubMed ID: 33582973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting Social Media for Active Pharmacovigilance: The PVClinical Social Media Workspace.
    Kakalou C; Dimitsaki S; Dimitriadis VK; Natsiavas P
    Stud Health Technol Inform; 2022 Jun; 290():739-743. PubMed ID: 35673115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Social Media in Detecting Drug Safety-Related New Black Box Warnings, Labeling Changes, or Withdrawals: Scoping Review.
    Lee JY; Lee YS; Kim DH; Lee HS; Yang BR; Kim MG
    JMIR Public Health Surveill; 2021 Jun; 7(6):e30137. PubMed ID: 34185021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
    Zhou Z; Hultgren KE
    JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review.
    Lardon J; Abdellaoui R; Bellet F; Asfari H; Souvignet J; Texier N; Jaulent MC; Beyens MN; Burgun A; Bousquet C
    J Med Internet Res; 2015 Jul; 17(7):e171. PubMed ID: 26163365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media.
    Comfort S; Perera S; Hudson Z; Dorrell D; Meireis S; Nagarajan M; Ramakrishnan C; Fine J
    Drug Saf; 2018 Jun; 41(6):579-590. PubMed ID: 29446035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams.
    Eshleman R; Singh R
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):335. PubMed ID: 27766937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Twitter as a complementary data source for pharmacovigilance.
    Lardon J; Bellet F; Aboukhamis R; Asfari H; Souvignet J; Jaulent MC; Beyens MN; Lillo-LeLouët A; Bousquet C
    Expert Opin Drug Saf; 2018 Aug; 17(8):763-774. PubMed ID: 29991282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BERT-based language model for accurate drug adverse event extraction from social media: implementation, evaluation, and contributions to pharmacovigilance practices.
    Dong F; Guo W; Liu J; Patterson TA; Hong H
    Front Public Health; 2024; 12():1392180. PubMed ID: 38716250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.
    Vilar S; Friedman C; Hripcsak G
    Brief Bioinform; 2018 Sep; 19(5):863-877. PubMed ID: 28334070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance?
    Bagheri H; Lacroix I; Guitton E; Damase-Michel C; Montastruc JL
    Therapie; 2016 Apr; 71(2):235-9. PubMed ID: 27080844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.
    Karapetiantz P; Audeh B; Redjdal A; Tiffet T; Bousquet C; Jaulent MC
    J Med Internet Res; 2024 Jun; 26():e46176. PubMed ID: 38888956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeepADEMiner: a deep learning pharmacovigilance pipeline for extraction and normalization of adverse drug event mentions on Twitter.
    Magge A; Tutubalina E; Miftahutdinov Z; Alimova I; Dirkson A; Verberne S; Weissenbacher D; Gonzalez-Hernandez G
    J Am Med Inform Assoc; 2021 Sep; 28(10):2184-2192. PubMed ID: 34270701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: "Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts".
    Magge A; Sarker A; Nikfarjam A; Gonzalez-Hernandez G
    J Am Med Inform Assoc; 2019 Jun; 26(6):577-579. PubMed ID: 31087070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.